Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Safety and Efficacy Study of Etanercept In Children With Systemic Onset Juvenile Rheumatoid Arthritis

NCT00078806 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00078806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Safety and Efficacy Study of Etanercept In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Terminated
Start date
June 4, 2001
Completion date
May 6, 2004
Enrollment
19 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile rheumatoid arthritis